英卡思学院

介绍
大会日程
讲者
赞助企业名单
认证

Asia 2019
大会日程

聚焦 S030

Melasma

会议室： Room 3B
日期： 2019年 7月 5日星期五从 15:00 至 16:00
组织形式： 聚焦课程 > 涵盖大会的一个主要议题
目标： 1. Identify different treatment options for melasma 2. Elaborate on and emerging treatment plans for melasma 3. Discuss how to apply strategies to treat melasma for Asian patients

主席

Moshe LAPIDOTH 医师

皮肤科医师

以色列

Maylita SARI 医师

皮肤科医师

印度尼西亚

本场演讲内容

小时	讲者	演讲标题	讲稿摘要	数字
15:00	Nariaki MIYATA 医师	New technology for melasma - Full face treatment by using 3 wavelength picosecond laser	查看	86278
15:12	Teresita Santillan FERRARIZ 医师	PRP as adjuvant treatment for melasma	查看	86443
15:24	Wichai HONGCHARU 医师	The science behind picosecond laser treatment for recalcitrant melasma		86245
15:36	Prasetyadi MAWARDI 医师	The hydroquinon-free bleaching agent for Asian ethnic melasma	查看	84658
15:48	Seiko KOU 医师	The strategy of the balance of stability in Asian melasma and improvement of skin rejuvenation	查看	88241
15:56		Questions and answers		88243

进入前一场会议

进入下一场会议

推荐会议

黄褐斑

色素沉着

激光

皮肤光老化

皮肤老化

Nariaki MIYATA 医师

整形外科医师

日本

其他作者 :

New technology for melasma - Full face treatment by using 3 wavelength picosecond laser

Objectives: Melasma treatment by using picosecond laser is effective and safe. However, melasma is usually complicated by various kinds of pigmentations. Therefore, laser irradiation with single wavelength and pulse duration is not enough for getting better results. How to combine the handpiece for melasma (& pigmentation) removal in technological aspect?

Introduction: Recently, picosecond laser treatments have been introduced and it has proven better outcomes and minimal complications for tattoo treatment. High photo-acoustic effect dramatically change the tattoo treatment.
However, pigmentation especially melasma treatment is more important issue for Asians, compared with tattoo treatment.
We should find the ideal setting of picosecond lasers for melasma treatment.

Materials / method: Laser irradiation combined with 3 different handpieces (532 nm axicon lens fractional, 785/730 nm titan-sapphire, 1064 nm large spot size) on same day was performed.

Results: We found measurable change by image analysis system and by clinical photos.

Conclusion: To treat melasma, pulse duration is important issue. However, there are large difference according to the model of picosecond laser devices. Shorter pulse duration with low fluence is better for treatment of melasma safely. Within stress relaxation time (SRT), shock wave is localized in melanosome.
And more, for Asians, picosecond laser need evolution and expanded utilization.
New wavelength and fractional handpiece of picosecond laser are required for patients’ satisfaction. In technological aspect, I will show ideal combination of picosecond laser irradiation for melasma treatment.

利益冲突声明

您有否接受任何资金来支持研究这个主题？
否

您是否接受过关于这项研究的任何酬金或其他报酬？
否

你是否和任何与您的研究所涉及的药物，材料或工具有密切联系的实体存在财务关系？
是
请注明名称（个人，公司，学会等等）: KOL for Candela

你是否拥有或者您已经为您此研究中的工具，药物或材料申请任何专利？
否

这项工作没有任何直接或间接的资金支持。由作者自己承担责任。

Teresita Santillan FERRARIZ 医师

皮肤科医师

菲律宾

其他作者 :

PRP as adjuvant treatment for melasma

Objectives: The objective of this lecture is to show the effect of Platelet Rich Plasma (PRP ) in the treatment of Melasma.

Introduction: Melasma is a common acquired disorder of hyperpigmentation char. by light brown to gray patches seen in the face and caused by several factors like heredity,UV radiation, hormonal changes, etc..Principles of Melasma Rx are protection from sun exposure, inhibition of Tyrosinase activity and removal and disruption of melanin granules.Treatment of Melasma has always been a big challenge for both patients and dermatologists as it can be resistant to diff therapeutic approaches and high relapse rate.So there's need for other treatment options like PRP, an autologous plasma containing GF/cytokines.

Materials / method: PRP kits includes Test tube with anticoagulant
EMLA,Centrifuge,Syringes-10,5,1 mls,g 30 needles
Method:
Extraction of 8 ml blood from the patient and placed in an anti coagulated test tube and centrifuged(Regen lab) for 8 min at 3500 RPM,separating the platelets from the rest of the blood.Then 5 ml of PRP is pipetted from the test-tube and transferred to 5 1 ml syringes.The Prp is then ready for injections to target areas.

Results: Improvement is seen 3-4 weeks after first injection.Aside from attenuation of pigmentation,improvement of skin texture is seen.But it needs several treatments at 2-4 weeks interval for more dramatic results.
Of course, it is not a stand alone treatment.Other standard treatment options like bleaching agents, antioxidants,Vit C,Tranexamic acid,Intraceutical Oxygen facial were given either before, during or after PRP depending on the response of the patient.

Conclusion: PRP may serve as an adjunct or alternative treatment of long standing Melasma or to other skin conditions with currently no gold standard mode of therapy.

PRP is not a stand alone treatment.For optimal result, it may be combined with other treatment modalities like topicals (sunscreen, bleaching agents)micro needling,chemical peeling and lasers.

Effect of PRP on Melasma is probably secondary to the inhibition of Tyrosinase by Transforming Growth Factor-B1.
Further Studies are encouraged to substantiate the efficiency and safety of PRP.

利益冲突声明

您有否接受任何资金来支持研究这个主题？
否

您是否接受过关于这项研究的任何酬金或其他报酬？
否

你是否和任何与您的研究所涉及的药物，材料或工具有密切联系的实体存在财务关系？
否

你是否拥有或者您已经为您此研究中的工具，药物或材料申请任何专利？
否

这项工作没有任何直接或间接的资金支持。由作者自己承担责任。

Wichai HONGCHARU 医师

皮肤科医师

泰国

其他作者 :

The science behind picosecond laser treatment for recalcitrant melasma

Objectives: The picosecond laser is a groundbreaking innovation that can be applied for the removal of tattoos and the treatment of various pigmentary conditions., Picoway is the only device in its class to feature three wavelengths in a single platform: 1064 nm, 532 nm, and 785 nm. It also features the extremely short pulse duration at 300 ps; moreover, it provides selectable durations (300, 375, 450 PS).The shorter picosecond duration is better to acheive a selective photoacoustolysis on particles high peak power but low fluence approaches for melasma treatment.

Introduction: The present data indicate that there may be a size gradient of melanosomes encompassing the global complexion coloration and that the melanosome distribution in keratinocytes of Asian skin is intermediate between that in light Caucasian and dark African/American skin. in Asian skin (1•36 ± 0•15 μm2 × 10−2) . Melanosomes within keratinocytes of Asian skin are distributed as a combination of individual and clustered melanosomes with a proportion of 62•6% vs. 37•4%, respectively. The individual melanosome has larger size compared to cluster melanosomes. Melanosome has stress relaxation time<300PS

Materials / method: We studied retrospectively back on 100 melasma patients with Picoway toning. We selected the melasma patients who have not response to tranxaminic acid (either oral or intralesionl administration) or other laser toning for picoway treatment. Patients received 450ps alone or 450 ps plus 350ps or 450ps plus 300ps laser.

Results: We found most patients have a good satisfaction rates with 450ps in dark brown skin group. For light brown skin group, parameters require 450ps plus 350 or 300ps laser. Certain parameters are required for better results. Mostly are the parameters with low fluences and higher >10 repetition rates. Adding shorter picosecond pulse duration gives long-term improvement >1year.

Conclusion: In summary, Ultrashort picosecond laser give a promising results for the treatment of refractory melasma. The application various ultrashort pulse durations is recommended to get rid of various type and size of melanosomes

利益冲突声明

您有否接受任何资金来支持研究这个主题？
否

您是否接受过关于这项研究的任何酬金或其他报酬？
否

你是否和任何与您的研究所涉及的药物，材料或工具有密切联系的实体存在财务关系？
否

你是否拥有或者您已经为您此研究中的工具，药物或材料申请任何专利？
否

这项工作没有任何直接或间接的资金支持。由作者自己承担责任。

Prasetyadi MAWARDI 医师

皮肤科医师

印度尼西亚

其他作者 :

The hydroquinon-free bleaching agent for Asian ethnic melasma

Objectives: The purpose of this topic is to provide alternative treatment options for melasma that is often suffered by Asian women, whichlong-term use of hydroquinone will cause ocronosis.. It is the most commonly studied agent for lightening pigment. It inhibits the activity of tyrosinase, the enzyme necessary for melanin biosynthesis. Some non hydroquinone bleaching agents have been developed, such as tretinoin, glucosamine, retinol, retinaldehyde, N-acetyl glucosamine, arbutin, vitamin C, as alternative therapy for melasma

Introduction: Melasma is a common acquired hypermelanosis involving face, which lasts for long period resulting in psychological problems and decreased quality of life. It affects all races but it is more prevalent in those with darker skin types. South East Asian ethnics with melasma have been highly reported. The Asian ethnic becomes an important ethnic group due to their different characteristics, way of life and peculiar habits. It tends to present post-inflammatory hyperpigmentation, melasma, lentigenes, freckles, Ota and Hori nevi. Multiple causative factors have been identified for melasma.

Conclusion: The use of non hydroquinone topical , remain to develope as an alternative therapy for melasma in Asian women, to reduce side effects and adverse events caused by long-term use of hydroquinone.

利益冲突声明

您有否接受任何资金来支持研究这个主题？
否

您是否接受过关于这项研究的任何酬金或其他报酬？
否

你是否和任何与您的研究所涉及的药物，材料或工具有密切联系的实体存在财务关系？
否

你是否拥有或者您已经为您此研究中的工具，药物或材料申请任何专利？
否

这项工作没有任何直接或间接的资金支持。由作者自己承担责任。

Seiko KOU 医师

医师

日本

其他作者 :

The strategy of the balance of stability in Asian melasma and improvement of skin rejuvenation

Objectives: The primary objective of this study focuses on the control of melasma, which is a functional irregularity of melanocyte among Asian, and rejuvenation of the entire skin layers. This study suggests the strategy of the balance of stability in melasma and improvement of skin rejuvenation.

Introduction: There is a variety of advanced skin rejuvenation devices such as, the pico-second laser, but it is difficult to achieve skin rejuvenation accompanying melasma in Asian patients by short-term treatment by means of a single device alone. It is necessary to select the most appropriate device for the conditions of each patient’s melasma assessed through diagnostic imaging. As a premaise, conservative therapy such as external and internal medicine have already or simultaneously be treated. the strategy of the balance of stability in melasma and improvement of skin rejuvenation will discussed.

Materials / method: There were 493 melasma patients that our facilities followed for over 12 months between August 2008 and May 2019. Oral administration included tranexamic acid,etc.while one of hydroquinone cream,etc was used for external administration.Infusion of highly concentrated Vitamin C could also be applied.Treatment by devices included IPL ,Nano-second, pico-second, long pulse NdYAG Laser, Nano-second Ruby Laser, Plasma, Non-abrasive, abrasive fractional laser, CO2 Laser and electroporation, etc.Customized treatment was designed based on the diagnostic imaging. VISIA-EVOLUTION○R was used for visual e

Results: There were 161 cases of Severe level and 332 cases of Slight level. 85% of the Severe level and 48% of the Sight level were improved. Pico-second Laser showed a higher improvement rate than the conventional treatment cases. There were 12 cases (7%) of “Worsened” from the Severe level, of which 6 cases were not eligible for oral administration of tranexamic acid. On the overall, this long-term clinical case (over 1 year) indicated a balanced result in terms of an improvement of dermis and stability of melasma.

Conclusion: The fundamental approach for photoaging skin with melasma is the conservative treatment by means of oral administration of tranexamic acid. The important point in establishing a long-term stability of melasma during skin rejuvenation is to determine the best selection of Long pulse laser, Nano-second laser, or Pico-second laser, that can be applied each time with least stimulus to the melanocyte. This would be the bases on which the temporal change of pigmentation in melasma should be judged by using image diagnostics.

利益冲突声明

您有否接受任何资金来支持研究这个主题？
否

您是否接受过关于这项研究的任何酬金或其他报酬？
否

你是否和任何与您的研究所涉及的药物，材料或工具有密切联系的实体存在财务关系？
否

你是否拥有或者您已经为您此研究中的工具，药物或材料申请任何专利？
否

这项工作没有任何直接或间接的资金支持。由作者自己承担责任。

Questions and answers

您有问题要问？

在我们的常见问题解答中快速找到答案

大会

英卡思美洲大会
英卡思亚洲年会
英卡思巴黎国际年会

关于我们

公司
隐私政策
法律信息

学院

主页
课程
Webinars
探索
博客

支援

教育援助

保持联系

联系我们

登录名/电邮地址

密码

保持登录状态

密码遗失 ? 还没有账号？现在注册

保持登录状态

academy.Do_not_have_an_account_yet 现在注册

Asia 2019 大会日程

聚焦 S030

Melasma

主席

本场演讲内容

推荐会议

Asia 2019
大会日程

本场演讲内容